PROCEPT BioRobotics Corp (NAS:PRCT)
$ 63.17 -0.31 (-0.49%) Market Cap: 3.25 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 12.29 GF Score: 40/100

PROCEPT BioRobotics Corp at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / 05:45PM GMT
Release Date Price: $35.08 (-4.93%)
Lisa Cohen

Good morning, everyone. Welcome back to the 41st Annual J.P. Morgan Healthcare Conference. Great to see everyone's faces in the flesh this year. My name is Lisa Cohen. I am an associate out in San Francisco, with our healthcare investment banking team. So I'm very excited to introduce today PROCEPT BioRobotics. We have 3 wonderful speakers here with us. Reza Zadno, the CEO; Kevin Waters, the CFO; and Matt Bacso, the VP of Investor Relations.

So with that, I will pass it off to Reza to show their story.

Reza Zadno
PROCEPT BioRobotics Corporation - President, CEO & Director

Thanks, Lisa. Good morning, everyone. Reza Zadno, CEO at PROCEPT, very excited to be here to present our company. We are a surgical robotic company, and our vision is to become the standard of care in treatment of BPH, which is the #1 reason patients, men, see a urologist, massive market.

Please review our safe harbor statement. Today with me, our Chief Financial Officer, we have an experienced management team from high-growth companies and multiple public

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot